Dana-Farber Cancer Institute
655 recruiting clinical trials across 23 locations in Massachusetts, New Hampshire.
Conditions studied across this network
Ovarian CancerAdvanced Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal CancerPARP InhibitorFatigue Related to Cancer TreatmentFatigue in Cancer SurvivorsBreast CancerMetastatic Head-and-neck Squamous-cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaLocally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment RegimenChronic Lymphocytic Leukemia